SPY753.40+0.09%QQQ679.97+0.09%BTC/USD74,970.44−0.38%DIA523.71+0.07%GLD378.80−0.19%TLT81.80−0.19%

Premium Services

Premium Services

P3 Health Partners Inc

PIIINASDAQ

Trade with Public

Trade with Public

$4.25

0.256.25%

Last update: Nov 6, 5:21 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

P3 Health Partners (PIII) Stock Price Target 2026 & Analyst Forecast - Benzinga

P3 Health Partners (PIII) Stock Price Target 2026

The average analyst price target for P3 Health Partners is $15.13, 278.3% above the current price. Of 3 analysts, 1 rates it Buy and 2 Hold. Targets range from $12.50 to $20. The latest change came on May 22, 2026, when TD Cowen raised its price target on P3 Health Partners from $3 to $14 and kept a Hold rating.

The Average Analyst Price Target for P3 Health Partners is $15.13.

Price Target Range — 7 Quarters

Analyst Consensus — 3 Analysts

1Buy

2Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$15.13Upside to Avg. PT+278.3%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for P3 Health Partners Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 22, 2026	TD Cowen	Ryan Langston	PT Raise	Hold	$3→$14
May 15, 2026	Lake Street	Ben Haynor	PT Raise	Buy	$4→$14
Apr 2, 2026	TD Cowen	Ryan Langston	PT Cut	Hold	$8→$3
Mar 27, 2026	Lake Street	Ben Haynor	PT Cut	Buy	$13→$4
Dec 12, 2025	BTIG	David Larsen	Suspends	Neutral	—
Nov 17, 2025	Lake Street	Ben Haynor	PT Cut	Buy	$20→$13
Aug 28, 2025	Lake Street	Ben Haynor	Assumes	Buy	$20
Apr 21, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$50→$20
Nov 20, 2024	TD Cowen	Gary Taylor	PT Cut	Hold	$45→$13
Apr 1, 2024	BTIG	David Larsen	Downgrade	Buy→Neutral	—
Mar 14, 2024	Lake Street	Brooks O'Neil	PT Cut	Buy	$450→$225

Analyst Ratings News

PRO
TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $12.5

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $50 to $20.

Benzinga Newsdesk